UBS AM’s Ionis Pharmaceuticals IONS Stock Holding History

UBS AM’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$111M	Buy	1,475,632 +87,065	+6%	+$6.87M	0.02%	490
2025 Q4	$110M	Buy	1,388,567 +234,401	+20%	+$17.6M	0.02%	474
2025 Q3	$75.5M	Buy	1,154,166 +363,094	+46%	+$17.7M	0.02%	532
2025 Q2	$31.3M	Buy	791,072 +131,637	+20%	+$4.31M	0.01%	868
2025 Q1	$19.9M	Buy	659,435 +39,794	+6%	+$1.3M	0.01%	968
2024 Q4	$21.7M	Buy	619,641 +333,944	+117%	+$12.5M	0.01%	913
2024 Q3	$11.4M	Sell	285,697 -34,593	-11%	-$1.61M	﹤0.01%	1162
2024 Q2	$15.3M	Buy	320,290 +133,963	+72%	+$5.49M	﹤0.01%	970
2024 Q1	$8.08M	Hold	186,327	–	–	﹤0.01%	1075
2023 Q4	$9.43M	Buy	186,327 +9,213	+5%	+$441K	﹤0.01%	1007
2023 Q3	$8.03M	Buy	177,114 +381	+0.2%	+$15.7K	﹤0.01%	1024
2023 Q2	$6.32M	Hold	176,733	–	–	﹤0.01%	1131
2023 Q1	$6.32M	Buy	176,733 +937	+0.5%	+$35.2K	﹤0.01%	1131
2022 Q4	$6.64M	Sell	175,796 -103,828	-37%	-$4.37M	﹤0.01%	1080
2022 Q3	$12.4M	Buy	279,624 +73,835	+36%	+$3.11M	0.01%	890
2022 Q2	$7.62M	Sell	205,789 -1,117	-0.5%	-$42.1K	﹤0.01%	1074
2022 Q1	$7.66M	Buy	206,906 +23,154	+13%	+$758K	﹤0.01%	1173
2021 Q4	$5.59M	Buy	183,752 +3,087	+2%	+$97.2K	﹤0.01%	1364
2021 Q3	$6.06M	Buy	180,665 +4,324	+2%	+$163K	﹤0.01%	1280
2021 Q2	$7.03M	Sell	176,341 -228,183	-56%	-$8.94M	﹤0.01%	1239
2021 Q1	$18.2M	Sell	404,524 -4,987	-1%	-$278K	0.01%	884
2020 Q4	$23.2M	Buy	409,511 +60,612	+17%	+$3.02M	0.01%	811
2020 Q3	$16.6M	Buy	348,899 +10,259	+3%	+$570K	0.01%	822
2020 Q2	$20M	Sell	338,640 -22,092	-6%	-$1.23M	0.01%	739
2020 Q1	$17.1M	Buy	360,732 +7,186	+2%	+$401K	0.01%	718
2019 Q4	$21.4M	Buy	353,546 +16,312	+5%	+$972K	0.01%	756
2019 Q3	$20.2M	Buy	337,234 +1,207	+0.4%	+$78.7K	0.01%	764
2019 Q2	$21.6M	Buy	336,027 +207,590	+162%	+$14.7M	0.02%	739
2019 Q1	$10.4M	Buy	128,437 +15,815	+14%	+$1.02M	0.01%	924
2018 Q4	$6.09M	Buy	112,622 +5,066	+5%	+$258K	0.01%	1018
2018 Q3	$5.55M	Buy	107,556 +1,264	+1%	+$59.4K	﹤0.01%	1116
2018 Q2	$4.43M	Sell	106,292 -174,781	-62%	-$7.75M	﹤0.01%	1199
2018 Q1	$12.4M	Sell	281,073 -5,444	-2%	-$277K	0.01%	875
2017 Q4	$14.4M	Buy	286,517 +16,323	+6%	+$895K	0.01%	823
2017 Q3	$13.7M	Buy	270,194 +6,357	+2%	+$333K	0.01%	825
2017 Q2	$13.4M	Sell	263,837 -54,523	-17%	-$2.54M	0.01%	848
2017 Q1	$12.8M	Buy	318,360 +10,877	+4%	+$489K	0.01%	845
2016 Q4	$14.7M	Sell	307,483 -20,388	-6%	-$807K	0.02%	776
2016 Q3	$12M	Sell	327,871 -142,934	-30%	-$4.47M	0.01%	843
2016 Q2	$11M	Sell	470,805 -496,401	-51%	-$16M	0.01%	859
2016 Q1	$39.2M	Buy	967,206 +35,210	+4%	+$1.43M	0.05%	430
2015 Q4	$57.7M	Sell	931,996 -58,266	-6%	-$3.14M	0.07%	313
2015 Q3	$40M	Buy	990,262 +4,631	+0.5%	+$240K	0.04%	440
2015 Q2	$56.7M	Buy	985,631 +71,651	+8%	+$4.56M	0.05%	374
2015 Q1	$58.2M	Buy	913,980 +163,083	+22%	+$11.1M	0.06%	382
2014 Q4	$46.4M	Sell	750,897 -40,800	-5%	-$2.01M	0.04%	438
2014 Q3	$30.7M	Buy	791,697 +33,700	+4%	+$1.19M	0.03%	570
2014 Q2	$26.1M	Buy	757,997 +340,000	+81%	+$10.7M	0.03%	606
2014 Q1	$18.1M	Buy	417,997 +60,800	+17%	+$2.95M	0.02%	689
2013 Q4	$14.2M	Buy	357,197 +126,840	+55%	+$4.52M	0.02%	728
2013 Q3	$8.65M	Buy	230,357 +180,860	+365%	+$5.4M	0.01%	843
2013 Q2	$1.33M	Buy	+49,497	New	+$1.05M	﹤0.01%	1351